LONG COVID19
Clinical trials for LONG COVID19 explained in plain language.
Never miss a new study
Get alerted when new LONG COVID19 trials appear
Sign up with your email to follow new studies for LONG COVID19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can tailored rehab help long COVID patients get moving again?
Symptom relief OngoingThis study tests whether a personalized cardiopulmonary rehabilitation program can help people with Long COVID who struggle with exercise intolerance and post-exertional malaise. About 360 participants will do 2-3 supervised sessions per week for 12 weeks, including aerobic exerc…
Matched conditions: LONG COVID19
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Could a common Weight-Loss drug shield the brain? early trial launches
Knowledge-focused TerminatedThis pilot study tests whether liraglutide (Saxenda), a weight-loss drug, can raise levels of a brain-protective protein called BDNF in 30 people with multiple sclerosis, long-COVID, or leukemia who are overweight and have memory or concentration problems. Participants will injec…
Matched conditions: LONG COVID19
Phase: EARLY_PHASE1 • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC